- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Apricus Biosciences Inc+ Add to Watchlist
APRI:US0.9980 USD 0.0620 5.85%
As of 17:20:00 ET on 12/18/2014.
Company Profile for Apricus Biosciences Inc (APRI)
Apricus Biosciences Inc. is a bio-technology company. The Company is seeking to monetize its existing product pipeline, including compounds from pre-clinical through Phase 3, currently focused on dermatology, sexual dysfunction and cancer.
Apricus Biosciences Inc
Key Executives for Apricus Biosciences Inc (APRI)
|Richard W PascoeChief Executive Officer||Brian T DorseyChief Development Officer|
|Barbara TroupinChief Medical Officer|